Zobrazeno 1 - 10
of 15
pro vyhledávání: '"T Iu, Dubskaia"'
Autor:
V Iu, Usov, M L, Balianin, A I, Bezlepkin, A A, Churin, T Iu, Dubskaia, T L, Vetoshkina, V D, Filimonov
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 76(10)
Preclinical evaluation of a 0.5 M solution of the manganese(II)- trans-1,2-diaminocyclohexane-N,N,N',N'-tetraacetate complex (Mn-DCTA, Cyclomang) has been carried out with a view to substitution of potentially toxic gadolinium-containing paramagnetic
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (11)
The influence of various antineoplastic preparations (farmorubicin, paclitaxel, etoposide, platidiam) on morphological and functional status of the liver in experimental animals was studied. It is shown, that all these antineoplastic drugs possess st
Autor:
A A, Churin, G V, Karpova, T I, Fomina, T V, Vetoshkina, T Iu, Dubskaia, O L, Voronova, V D, Filimonov, M L, Belianin, V Iu, Usov
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 71(4)
We have carried out a preclinical toxicological investigation (acute toxicity evaluation) of Mangascan (0.5 M solution of manganese(II) - EDTA complex) and Pentamang (0.5 M solution of manganese(II) - DTPA complex), a new paramagnetic contrast agents
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 69(1)
Irinotecan (campto) and etoposide cause the loss cells due to apoptosis, the early development of hypoplasia in bone marrow and lymphoid organs, and pancytopenia in peripheral blood upon single intravenous injection in maximum tolerated doses to whit
Autor:
G V, Karpova, T I, Fomina, T V, Vetoshkina, T G, Borovskaia, O L, Voronova, T Iu, Dubskaia, N I, Suslov, E V, Abramova, O P, Loskutova, E Iu, Sherstoboev, V G, Pashinskiĭ, T N, Povet'eva, A A, Semenov
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 65(3)
The safety of bayacon, a new drug based on Baikal aconite intended for the treatment of inflammation-proliferative dermatitis (psoriasis), was studied on a preclinical level. With respect to a single introduction in rats and mice, the drug is classif
Autor:
G V, Karpova, T I, Fomina, T V, Vetoshkina, T G, Borovskaia, O L, Voronova, T Iu, Dubskaia, V V, Udut, M Iu, Khlusova
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 64(1)
A new D-glucuronic acid (DGA) preparation was studied for toxicological safety on a preclinical level. The results obtained upon a single acute DGA administration in rats, mice, and rabbis showed that the drug exhibits moderate toxicity. A one-month
Autor:
G V, Karpova, T I, Fomina, T V, Vetoshkina, T G, Borovskaia, O L, Voronova, T Iu, Dubskaia, M E, Poluéktova, E A, Timina, E S, Smol'ianinov, V F, Turetskova
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 63(4)
A new drug preparation ecorsin based on the dry aspen bark extract was studied for toxicological safety on a preclinical stage. The drug exhibited no toxicity upon a single administration to rats and mice (both male and female). The intragastric admi
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 62(1)
A single intravenous infusion of 4.5 mg/kg of the new antineoplastic drug platidium induces structural-metabolic changes in the liver of rats (necrosis of hepatocytes, decrease of the glycogen and RNA content and accumulation of lipids in the cytopla
Publikováno v:
Biulleten' eksperimental'noi biologii i meditsiny. 126(11)
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 61(1)
It was shown in experiments on rats that intravenous infusion of the antitumor drug vepesid in a maximum tolerated dose causes stimulation of free-radical oxidation and changes in the fractional composition of lipids and phospholipids in the hepatic